Filing Details

Accession Number:
0000950170-24-003332
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-09 16:08:12
Reporting Period:
2024-01-08
Accepted Time:
2024-01-09 16:08:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1111485 Rxsight Inc. RXST Ophthalmic Goods (3851) 943268801
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295469 Md M Ronald Kurtz C/O Rxsight, Inc.
100 Columbia
Aliso Viejo CA 92656
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-01-08 31,250 $43.50 835,860 No 4 S Indirect See footnote
Common Stock Disposition 2024-01-08 31,250 $45.00 804,610 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 40,000 Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2023 by the Reporting Person.
  2. Shares held by Cricklewood LP. The Reporting Person is the manager of the general partner of Cricklewood LP and shares voting and investment control of the general partner of Cricklewood LP with his spouse.
  3. Represents the weighted average share price of an aggregate total of 31,250 shares sold in the price range of $45.00 to $45.02 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.